[1]
Pimsa, P. 2026. Progression Free Survival with Erlotinib in First Line Treatment EGFR Mutated Non-Small Cell Lung Cancer Stage IV in Sunpasitthiprasong Hospital. Journal of Health Science Boromarajonani College of Nursing Sunpasitthiprasong. 10, 1 (Apr. 2026), e287170 .